{"id":446450,"title":"Notice of Amendment: Iron derivatives for human use on the Prescription Drug List (PDL) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T11:58:46.041000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-iron-derivatives-human-use.html?wbdisable=false","snippet":"Notice of Amendment: Iron derivatives for human use on the Prescription Drug List (PDL) October 4, 2024 Our file number: 24-109388-925 The purpose of this Notice of Amendment is to notify about the addition of 'ferric carboxymaltose' to the \"including (but not limited to)\" column…","rawSnapshotUrl":"/api/snapshots/raw/446450","browseUrl":"https://replay.healtharchive.ca/job-6/20260103115846/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/amendment-iron-derivatives-human-use.html?wbdisable=false#ha_snapshot=446450","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}